Cinnarizine (20 mg) + Dimenhydrinate (40 mg) Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Cinnarizine (20 mg) + Dimenhydrinate (40 mg) Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: Dual Antihistamine + CCB
✓ Pan-India Monopoly PCD
✓ 2 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Cinnarizine (20 mg) + Dimenhydrinate (40 mg) Tablet Brand Options (2 options)
Trumac Healthcare manufactures and supplies the following Cinnarizine (20 mg) + Dimenhydrinate (40 mg) Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Cinnarizine (20 mg) + Dimenhydrinate (40 mg) Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Cinnarizine (20 mg) + Dimenhydrinate (40 mg) formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Severe vertigo
- Acute Meniere's disease attacks
- Severe motion sickness
- Vestibular crises
Mechanism of Action
Cinnarizine + Dimenhydrinate provide dual vestibular suppression through different antihistamine mechanisms. Synergistic effect on vertigo control.
Dosage & Administration
- Adults: 1 tablet two to three times daily.
Side Effects
- Drowsiness (more pronounced than Erito-25), dry mouth, blurred vision.
Contraindications
- Hypersensitivity.
- Glaucoma.
- Severe respiratory disease.
Storage
Store below 30 °C in a dry place, protected from light and moisture.
PCD Pharma Franchise for Cinnarizine (20 mg) + Dimenhydrinate (40 mg) Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 10 x 10 (Alu-Alu)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 2 brand options for Cinnarizine (20 mg) + Dimenhydrinate (40 mg) Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Cinnarizine (20 mg) + Dimenhydrinate (40 mg) Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Cinnarizine (20 mg) + Dimenhydrinate (40 mg) Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of Cinnarizine (20 mg) + Dimenhydrinate (40 mg) Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Cinnarizine (20 mg) + Dimenhydrinate (40 mg) Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer Cinnarizine (20 mg) + Dimenhydrinate (40 mg) Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Cinnarizine (20 mg) + Dimenhydrinate (40 mg) Tablet?
Available pack sizes include: 10 x 10 (Alu-Alu).
What is the MRP / trade price for Cinnarizine (20 mg) + Dimenhydrinate (40 mg) Tablet?
MRPs range from ₹1020 to ₹1089 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Cinnarizine (20 mg) + Dimenhydrinate (40 mg) Tablet?